GNH USA

Europe — EMA

Novorapid Flextouch (Insulin Aspart)

Insulin aspart, the active ingredient in Novorapid Flextouch, is a rapid-acting insulin analog presented as a solution for subcutaneous injection use. It controls blood glucose levels in people with diabetes mellitus.

Request sourcing

1
Pack/s

What is Insulin Aspart?

Insulin aspart, the active ingredient in Novorapid Flextouch, is a rapid-acting insulin analog presented as a solution for subcutaneous injection use. It controls blood glucose levels in people with diabetes mellitus. GNH USA supplies Novorapid Flextouch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Novorapid Flextouch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Insulin Aspart used for?

Novorapid Flextouch is a rapid‑acting insulin analog that lowers        .... - Diabetes mellitus  ....  ....  ... 

What are the side effects of Insulin Aspart?

Common  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Insulin Aspart
Route
Subcutaneous Use
Manufacturer
Novo Nordisk A/S
Origin
EU

Related products